Results 1 to 10 of about 267,125 (312)
Pulmonology, 2020 Introduction Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential ...
Maria Laura Alberti +6 more
doaj +3 more sources
BJGP Open, 2021 Background: Long-term nitrofurantoin (NF) treatment can result in pulmonary and hepatic injury. Current guidelines do not outline the type or frequency of monitoring required for detection of these injuries.
Toby Peter Speirs +16 more
doaj +1 more source
Occupational Interstitial Lung Diseases
Immunology and Allergy Clinics of North America, 2023 Occupational exposures are directly causal or partially contributory to the development of interstitial lung diseases. A detailed occupational history, relevant high-resolution computed tomography findings, and where relevant additional histopathology, are required to make a diagnosis.
Hayley, Barnes, Ian, Glaspole
openaire +7 more sources
Interstitial lung disease [PDF]
European Respiratory Review, 2014 Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Antoniou, Katerina M. +5 more
openaire +4 more sources
A multidisciplinary approach to the diagnosis of antisynthetase syndrome
Frontiers in Medicine, 2022 Antisynthetase syndrome is a subtype of idiopathic inflammatory myopathy, strongly associated with the presence of interstitial lung disease. Diagnosis is made by identifying myositis-specific antibodies directed against aminoacyl tRNA synthetase, and ...
Matthew Wells +10 more
doaj +1 more source
Respiratory Research, 2023 Introduction Interstitial lung disease (ILD) may be difficult to distinguish from other respiratory diseases due to overlapping clinical presentation. Recognition of ILD is often late, causing delay which has been associated with worse clinical outcome ...
Iris G. van der Sar +6 more
doaj +1 more source
Genetic Interstitial Lung Disease [PDF]
Clinics in Chest Medicine, 2012 The interstitial lung diseases (ILDs), or diffuse parenchymal lung diseases, are a heterogeneous collection of more than 100 different pulmonary disorders that affect the tissue and spaces surrounding the alveoli. Patients affected by ILD usually present with shortness of breath or cough; for many, there is evidence of pulmonary restriction, decreased ...
Megan Stuebner, Devine +1 more
openaire +2 more sources
Telomeres in Interstitial Lung Disease [PDF]
Journal of Clinical Medicine, 2021 Interstitial lung diseases (ILD) encompass a group of conditions involving fibrosis and/or inflammation of the pulmonary parenchyma. Telomeres are repetitive DNA sequences at chromosome ends which protect against genome instability. At each cell division, telomeres shorten, but the telomerase complex partially counteracts progressive loss of telomeres ...
Stock, C, Renzoni, E
openaire +4 more sources
Predictors and changes of physical activity in idiopathic pulmonary fibrosis
BMC Pulmonary Medicine, 2022 Background Different clinical predictors of physical activity (PA) have been described in idiopathic pulmonary fibrosis (IPF), but studies are lacking evaluating the potential role of muscle strength and anxiety and depression symptoms in PA limitation ...
Diana Badenes-Bonet +15 more
doaj +1 more source
BMJ Open Respiratory Research, 2021 Introduction Antisynthetase syndrome (ASyS) is a rare autoimmune connective tissue disease (CTD), associated with autoantibodies targeting tRNA synthetase enzymes, that can present to respiratory (interstitial lung disease (ILD)) or rheumatology ...
Harsha Gunawardena +7 more
doaj +1 more source